CHRM2 and atrial fibrillation: In particular, autoantibodies against β1-adrenergic receptors or M2-acetylcholine muscarinic receptors have been considered potential contributors to the pathogenesis of AF, acting as sympathomimetic and parasympathomimetic agonists, respectively [4].